Coenzyme Q10 Market Size

Global Coenzyme Q10 Market size was valued at USD 692.2 million in 2023 and is poised to grow from USD 746.19 million in 2024 to USD 1360.82 million by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

Growing awareness regarding health benefits of coenzyme Q10, rising prevalence of cardiovascular disorders, high demand for anti-aging products, and surging consumption of nutraceuticals and dietary supplements are key factors driving the sales of coenzyme Q10.

Consumers are becoming more aware regarding the benefits offered by coenzyme Q10 to improve mitochondrial function, reducing oxidative stress and supporting cardiovascular health. Growing incidence of chronic disorders such as heart disease, chronic fatigue, and neurodegenerative disorders is expected to bolster the demand for coenzyme Q10 over the coming years.

Increasing aesthetic awareness among people driven by social media influence is boosting the adoption of anti-aging and skincare products around the world. Coenzyme Q10’s anti-aging and skin-rejuvenation properties are promoting its use in the development of anti-aging and skincare products as it neutralizes free radicals, reducing fine lines, wrinkles, and UV damage. High emphasis on health and wellness around the world has also boosted the consumption of dietary supplements and nutraceuticals. Use of coenzyme Q10 in the formulations is also estimated to present new opportunities in the long run.

Surging demand for functional food and beverages coupled with rising popularity of veganism are estimated to bolster the global coenzyme Q10 market growth through 2032. On the contrary, limited bioavailability in traditional form, high costs of production, competition from alternative antioxidants, limited consumer awareness in developing countries, and stringent regulatory approvals are slated to slow down the adoption of coenzyme Q10 across the forecast period and beyond.

Key Market Attributes

In April 2024, Beiersdorf, a German multinational personal care product manufacturer announced that it had developed an active ingredient to combat skin’s glycation process that causes aging and wrinkle formulation. The new ingredient was planned to be featured with coenzyme Q10 in the product launch of Nivea Q10 Dual Action Serum. The new ingredient was trademarked as Glycostop is claimed to prevent glycation reaction and prevent the formation of AGEs by up to 68%. The Nivea Q10 Dual Action Serum utilizes Glycostop along with coenzyme Q10 to protect skin against free radicals and fulfil the demand for anti-aging skincare products.

In July 2023, Boryung Consumer Healthcare, a subsidiary of healthcare investment company Boryung based in South Korea announced the launch of a new functional ingredient with coenzyme Q10 recommended to be taken once a day with water after meals. Boryung Coenzyme Q10 Max contains the maximum daily recommended amount of coenzyme Q10 to help reduce blood pressure and promote overall health. The product contains 100 mg of U.S.-sourced coenzyme Q10 along with 400 µg of Swiss-sourced folic acid. Additional ingredients in this product are Vitamin E and zinc. Boryung Coenxyme Q10 Max comes in ultra-compact mini capsules making them easier for consumers to swallow.

In June 2023, Bausch + Lomb Corporation, a leading eye health company based in Canada announced the PreserVision® AREDS 2 Formula soft gels plus coenzyme Q10 in the United States market. The new formulation is built as per recommendations from the National Eye Institute (NEI). The novel eye vitamin helps reduce the risk of moderate to advanced Age-related Macular Degeneration (AMD) progression in AMD patients through its unique two-in-one formulation. AMD is the prime cause of vision loss among people of the United States and this is why this new product is expected to gain massive popularity in the long run.